Lexaria Bioscience Corp.
100 – 740 McCurdy Road
Kelowna, BC Canada V1X 2P7
1-250-765-6424
January 7, 2021
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Ada D. Sarmento
Re: Lexaria Bioscience Corp.
Registration Statement on Form S-1
Filed January 7, 2021
File No. 333-250326
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Lexaria Bioscience Corp (the “Company”) hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. Eastern Daylight Time, January 11, 2021, or as soon as practicable thereafter.
|
| Very truly yours, |
|
|
|
|
|
|
| Lexaria Bioscience Corp. |
|
|
|
|
|
By: | /s/ Christopher Bunka |
|
| Christopher Bunka |
|
| Chief Executive Officer |
|